History
|
Since the 1930s, thimerosal has been used in biologics and vaccines for its ability to kill bacteria. As well, thimerosal prevents bacterial contamination in certain containers. Some of the vaccines that contain thimerosal have often been recommended for infants and young children in North America, including many recombinant vaccines such as hepatitis B, diphtheria, pertussis, acellular pertussis, meningitis, influenza, tetanus and Hib vaccines.
In 1999, the Food and Drug Association of the United States of America stated that mercury exposure from vaccines exceeded Federal Safety Guidelines. Government officials admitted they were not thinking logically when they failed to add up the cumulative exposure levels when new vaccines were added to the early infant vaccination schedule in the early 1990’s. The rate of autism a decade ago was 1 in 10,000. CDC research indicates that 1 in 150 children are autistic today. The dramatic rise in autism rates correlates with the increase in mercury doses. Thimerosal was first marketed in the mid 1930's and autism was first described as a new never before seen disorder in 1943, in children born in the 1930's.
|